Danish pharma major Novo Nordisk (NOV: N) has reported positive Phase III data for its experimental oral version of Wegovy (semaglutide), showing weight-loss benefits close to those of the already ...

The European Court of Auditors has warned that Europe still lacks a reliable system to prevent and manage medicine shortages, ...

A life-sciences startup based in South San Francisco, focused on developing bispecific antibodies for immune and inflammatory diseases.

Spanish biotech ARTHEx has closed an expanded series B financing round totaling $87 million, led by French state-backed ...

South Korean biotech Alteogen (KOSDAQ:196170) has secured European Commission clearance for Eyluxvi (ALT-L9), its biosimilar ...

Belgian biopharma UCB has announced three-year data from the BE HEARD trials for Bimzelx (bimekizumab) in moderate to severe ...

Indian drugmakers are urging the government to ensure generic drugs are excluded from an ongoing US investigation, warning ...

Prota Therapeutics, an Australian biotech developing novel oral immunotherapy treatments that induce remission of allergy, ...

US drugmaker Eli Lilly has announced that it plans to build a $5 billion manufacturing facility just west of Richmond, ...

Denmark’s ALK-Abelló has entered into a partnership agreement with China-based Changchun GeneScience Pharmaceutical (GenSci) ...

Switzerland-based Roivant and Priovant Therapeutics today announced positive results from the Phase III VALOR study ...

Ollin Biosciences has officially launched with $100 million in funding to advance a pipeline of therapies for ...